{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:53:09Z","timestamp":1793418789131,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T00:00:00Z","timestamp":1468454400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Tissue Res"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s00441-016-2457-z","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T06:03:15Z","timestamp":1468476195000},"page":"691-702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma"],"prefix":"10.1007","volume":"365","author":[{"given":"Liisa","family":"Nissinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Farshchian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilvi","family":"Riihil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli-Matti","family":"K\u00e4h\u00e4ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,14]]},"reference":[{"key":"2457_CR1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/1078-0432.CCR-08-0149","volume":"15","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Vijayalekshmi RV, Sung B (2009) Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res 15:425\u2013430","journal-title":"Clin Cancer Res"},{"key":"2457_CR2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.0022-202X.2005.23640.x","volume":"124","author":"K Ahokas","year":"2005","unstructured":"Ahokas K, Skoog T, Suomela S, Jeskanen L, Impola U, Isaka K, Saarialho-Kere U (2005) Matrilysin-2 (matrix metalloproteinase-26) is upregulated in keratinocytes during wound repair and early skin carcinogenesis. J Invest Dermatol 124:849\u2013856","journal-title":"J Invest Dermatol"},{"key":"2457_CR3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/1523-1747.ep12319441","volume":"109","author":"K Airola","year":"1997","unstructured":"Airola K, Johansson N, Kariniemi AL, K\u00e4h\u00e4ri VM, Saarialho-Kere UK (1997) Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol 109:225\u2013231","journal-title":"J Invest Dermatol"},{"key":"2457_CR4","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1038\/sj.onc.1207678","volume":"23","author":"R Ala-aho","year":"2004","unstructured":"Ala-aho R, Ahonen M, George SJ, Heikkil\u00e4 J, Grenman R, Kallajoki M, K\u00e4h\u00e4ri VM (2004) Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo. Oncogene 23:5111\u20135123","journal-title":"Oncogene"},{"key":"2457_CR5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM200103293441306","volume":"344","author":"M Alam","year":"2001","unstructured":"Alam M, Ratner D (2001) Cutaneous squamous-cell carcinoma. N Engl J Med 344:975\u2013983","journal-title":"N Engl J Med"},{"key":"2457_CR6","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jaad.2012.09.053","volume":"68","author":"B Berman","year":"2013","unstructured":"Berman B, Cockerell CJ (2013) Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation. J Am Acad Dermatol 68:S10\u2013S19","journal-title":"J Am Acad Dermatol"},{"key":"2457_CR7","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/carcin\/bgi123","volume":"26","author":"P Boukamp","year":"2005","unstructured":"Boukamp P (2005) Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 26:1657\u20131667","journal-title":"Carcinogenesis"},{"key":"2457_CR8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.celrep.2014.02.014","volume":"6","author":"MS Cho","year":"2014","unstructured":"Cho MS, Vasquez HG, Rupaimoole R, Pradeep S, Wu S, Zand B, Han HD, Rodriguez-Aguayo C, Bottsford-Miller J, Huang J, Miyake T, Choi HJ, Dalton HJ, Ivan C, Baggerly K, Lopez-Berestein G, Sood AK, Afshar-Kharghan V (2014) Autocrine effects of tumor-derived complement. Cell Rep 6:1085\u20131095","journal-title":"Cell Rep"},{"key":"2457_CR9","doi-asserted-by":"crossref","unstructured":"C\u00f3rdoba SR de, Jorge EG de (2008) Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin Exp Immunol 151:1\u201313","DOI":"10.1111\/j.1365-2249.2007.03552.x"},{"key":"2457_CR10","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.4049\/jimmunol.1201654","volume":"189","author":"L Corrales","year":"2012","unstructured":"Corrales L, Ajona D, Rafail S, Lasarte JJ, Riezu-Boj JI, Lambris JD, Rouzaut A, Pajares MJ, Montuenga LM, Pio R (2012) Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression. J Immunol 189:4674\u20134683","journal-title":"J Immunol"},{"key":"2457_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","volume":"25","author":"EI Deryugina","year":"2006","unstructured":"Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25:9\u201334","journal-title":"Cancer Metastasis Rev"},{"key":"2457_CR12","doi-asserted-by":"crossref","unstructured":"Duk JM, Groenier KH, Bruijn HW de, Hollema H, Hoor KA ten, Zee AG van der, Aalders JG (1996) Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma. J Clin Oncol 14:111\u2013118","DOI":"10.1200\/JCO.1996.14.1.111"},{"key":"2457_CR13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1158\/2159-8290.CD-11-0028","volume":"1","author":"S Durinck","year":"2011","unstructured":"Durinck S, Ho C, Wang NJ, Liao W, Jakkula LR, Collisson EA, Pons J, Chan SW, Lam ET, Chu C, Park K, Hong SW, Hur JS, Huh N, Neuhaus IM, Yu SS, Grekin RC, Mauro TM, Cleaver JE, Kwok PY, LeBoit PE, Getz G, Cibulskis K, Aster JC, Huang H, Purdom E, Li J, Bolund L, Arron ST, Gray JW, Spellman PT, Cho RJ (2011) Temporal dissection of tumorigenesis in primary cancers. Cancer Discov 1:137\u2013143","journal-title":"Cancer Discov"},{"key":"2457_CR14","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ajpath.2011.05.012","volume":"179","author":"M Farshchian","year":"2011","unstructured":"Farshchian M, Kivisaari A, Ala-Aho R, Riihil\u00e4 P, Kallajoki M, Gr\u00e9nman R, Peltonen J, Pihlajaniemi T, Heljasvaara R, K\u00e4h\u00e4ri VM (2011) Serpin peptidase inhibitor clade A member 1 (SerpinA1) is a novel biomarker for progression of cutaneous squamous cell carcinoma. Am J Pathol 179:1110\u20131119","journal-title":"Am J Pathol"},{"key":"2457_CR15","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/jid.2015.104","volume":"135","author":"M Farshchian","year":"2015","unstructured":"Farshchian M, Nissinen L, Siljam\u00e4ki E, Riihil\u00e4 P, Toriseva M, Kivisaari A, Ala-Aho R, Kallajoki M, Ver\u00e4j\u00e4nkorva E, Honkanen HK, Heljasvaara R, Pihlajaniemi T, Gr\u00e9nman R, Peltonen J, Peltonen S, K\u00e4h\u00e4ri VM (2015) EphB2 promotes progression of cutaneous squamous cell carcinoma. J Invest Dermatol 135:1882\u20131892","journal-title":"J Invest Dermatol"},{"key":"2457_CR16","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1096\/fj.03-0966fje","volume":"18","author":"NS Fedarko","year":"2004","unstructured":"Fedarko NS, Jain A, Karadag A, Fisher LW (2004) Three small integrin binding ligand N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases. FASEB J 18:734\u2013736","journal-title":"FASEB J"},{"key":"2457_CR17","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.molimm.2010.05.007","volume":"47","author":"VP Ferreira","year":"2010","unstructured":"Ferreira VP, Pangburn MK, Cort\u00e9s C (2010) Complement control protein factor H: the good, the bad, and the inadequate. Mol Immunol 47:2187\u20132197","journal-title":"Mol Immunol"},{"key":"2457_CR18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.sbi.2012.04.001","volume":"22","author":"F Forneris","year":"2012","unstructured":"Forneris F, Wu J, Gros P (2012) The modular serine proteases of the complement cascade. Curr Opin Struct Biol 22:333\u2013341","journal-title":"Curr Opin Struct Biol"},{"key":"2457_CR19","doi-asserted-by":"crossref","unstructured":"Genders RE, Mazlom H, Michel A, Plasmeijer EI, Quint KD, Pawlita M, Meijden E van der, Waterboer T, Fijter H de, Claas FH, Wolterbeek R, Feltkamp MC, Bouwes Bavinck JN (2015) The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study. J Invest Dermatol 135:1275\u20131282","DOI":"10.1038\/jid.2014.456"},{"key":"2457_CR20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","volume":"278","author":"C Gialeli","year":"2011","unstructured":"Gialeli C, Theocharis AD, Karamanos NK (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278:16\u201327","journal-title":"FEBS J"},{"key":"2457_CR21","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fonc.2015.00214","volume":"5","author":"V Gkretsi","year":"2015","unstructured":"Gkretsi V, Stylianou A, Papageorgis P, Polydorou C, Stylianopoulos T (2015) Remodeling components of the tumor microenvironment to enhance cancer therapy. Front Oncol 5:214","journal-title":"Front Oncol"},{"key":"2457_CR22","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/jid.2012.391","volume":"133","author":"K Gordon","year":"2013","unstructured":"Gordon K, Kochkodan JJ, Blatt H, Lin SY, Kaplan N, Johnston A, Swindell WR, Hoover P, Schlosser BJ, Elder JT, Gudjonsson JE, Getsios S (2013) Alteration of the EphA2\/Ephrin-A signaling axis in psoriatic epidermis. J Invest Dermatol 133:712\u2013722","journal-title":"J Invest Dermatol"},{"key":"2457_CR23","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0167-5699(99)01537-6","volume":"20","author":"A Gorter","year":"1999","unstructured":"Gorter A, Meri S (1999) Immune evasion of tumor cells using membrane-bound complement regulatory proteins. Immunol Today 20:576\u2013582","journal-title":"Immunol Today"},{"key":"2457_CR24","doi-asserted-by":"crossref","unstructured":"Graaf YG de, Rebel H, Elghalbzouri A, Cramers P, Nellen RG, Willemze R, Bouwes Bavinck JN, Gruijl FR de (2008) More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine. Exp Dermatol 17:349\u2013355","DOI":"10.1111\/j.1600-0625.2007.00651.x"},{"key":"2457_CR25","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/eji.1830230518","volume":"23","author":"J Greenwood","year":"1993","unstructured":"Greenwood J, Clark M, Waldmann H (1993) Structural motifs involved in human IgG antibody effector functions. Eur J Immunol 23:1098\u20131104","journal-title":"Eur J Immunol"},{"key":"2457_CR26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nri2231","volume":"8","author":"P Gros","year":"2008","unstructured":"Gros P, Milder FJ, Janssen BJ (2008) Complement driven by conformational changes. Nat Rev Immunol 8:48\u201358","journal-title":"Nat Rev Immunol"},{"key":"2457_CR27","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1158\/0008-5472.CAN-06-0004","volume":"66","author":"H Guo","year":"2006","unstructured":"Guo H, Miao H, Gerber L, Singh J, Denning MF, Gilliam AC, Wang B (2006) Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin. Cancer Res 66:7050\u20137058","journal-title":"Cancer Res"},{"key":"2457_CR28","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s13277-013-0842-8","volume":"34","author":"E Hadler-Olsen","year":"2013","unstructured":"Hadler-Olsen E, Winberg JO, Uhlin-Hansen L (2013) Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. Tumour Biol 34:2041\u20132051","journal-title":"Tumour Biol"},{"key":"2457_CR29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1373\/clinchem.2003.026849","volume":"50","author":"C Hafner","year":"2004","unstructured":"Hafner C, Schmitz G, Meyer S, Bataille F, Hau P, Langmann T, Dietmaier W, Landthaler M, Vogt T (2004) Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin Chem 50:490\u2013499","journal-title":"Clin Chem"},{"key":"2457_CR30","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/modpathol.3800660","volume":"19","author":"C Hafner","year":"2006","unstructured":"Hafner C, Becker B, Landthaler M, Vogt T (2006) Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer. Mod Pathol 19:1369\u20131377","journal-title":"Mod Pathol"},{"key":"2457_CR31","doi-asserted-by":"crossref","unstructured":"Hameetman L, Commandeur S, Bavinck JN, Wisgerhof HC, Gruijl FR de, Willemze R, Mullenders L, Tensen CP, Vrieling H (2013) Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients. BMC Cancer 13:58","DOI":"10.1186\/1471-2407-13-58"},{"key":"2457_CR32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/bj3260321","volume":"326","author":"J Hellwage","year":"1997","unstructured":"Hellwage J, Kuhn S, Zipfel PF (1997) The human complement regulatory factor-H-like protein 1, which represents a truncated form of factor H, displays cell-attachment activity. Biochem J 326:321\u2013327","journal-title":"Biochem J"},{"key":"2457_CR33","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1046\/j.1523-1747.2003.12533.x","volume":"121","author":"N Hieta","year":"2003","unstructured":"Hieta N, Impola U, L\u00f3pez-Ot\u00edn C, Saarialho-Kere U, K\u00e4h\u00e4ri VM (2003) Matrix metalloproteinase-19 expression in dermal wounds and by fibroblasts in culture. J Invest Dermatol 121:997\u20131004","journal-title":"J Invest Dermatol"},{"key":"2457_CR34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1600-0625.2010.01086.x","volume":"19","author":"GF Hofbauer","year":"2010","unstructured":"Hofbauer GF, Bouwes Bavinck JN, Euvrard S (2010) Organ transplantation and skin cancer: basic problems and new perspectives. Exp Dermatol 19:473\u2013482","journal-title":"Exp Dermatol"},{"key":"2457_CR35","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1038\/ncomms6932","volume":"6","author":"E Hoste","year":"2015","unstructured":"Hoste E, Arwert EN, Lal R, South AP, Salas-Alanis JC, Murrell DF, Donati G, Watt FM (2015) Innate sensing of microbial products promotes wound-induced skin cancer. Nat Commun 6:5932","journal-title":"Nat Commun"},{"key":"2457_CR36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ijc.10902","volume":"103","author":"U Impola","year":"2003","unstructured":"Impola U, Toriseva M, Suomela S, Jeskanen L, Hieta N, Jahkola T, Grenman R, K\u00e4h\u00e4ri VM, Saarialho-Kere U (2003) Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation. Int J Cancer 103:709\u2013716","journal-title":"Int J Cancer"},{"key":"2457_CR37","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1365-2133.2005.06447.x","volume":"152","author":"U Impola","year":"2005","unstructured":"Impola U, Jeskanen L, Ravanti L, Syrj\u00e4nen S, Baldursson B, K\u00e4h\u00e4ri VM, Saarialho-Kere U (2005) Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds. Br J Dermatol 152:720\u2013726","journal-title":"Br J Dermatol"},{"key":"2457_CR38","first-page":"499","volume":"15","author":"N Johansson","year":"1997","unstructured":"Johansson N, Airola K, Grenman R, Kariniemi AL, Saarialho-Kere U, K\u00e4h\u00e4ri VM (1997) Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 15:499\u2013508","journal-title":"Am J Pathol"},{"key":"2457_CR39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9440(10)65293-5","volume":"154","author":"N Johansson","year":"1999","unstructured":"Johansson N, Vaalamo M, Gr\u00e9nman S, Hietanen S, Klemi P, Saarialho-Kere U, K\u00e4h\u00e4ri VM (1999) Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol 154:469\u2013480","journal-title":"Am J Pathol"},{"key":"2457_CR40","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1158\/0008-5472.CAN-06-0662","volume":"66","author":"N Joshi","year":"2006","unstructured":"Joshi N, Johnson LL, Wei WQ, Abnet CC, Dong ZW, Taylor PR, Limburg PJ, Dawsey SM, Hawk ET, Qiao YL, Kirsch IR (2006) Gene expression differences in normal esophageal mucosa associated with regression and progression of mild and moderate squamous dysplasia in a high-risk Chinese population. Cancer Res 66:6851\u20136860","journal-title":"Cancer Res"},{"key":"2457_CR41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/exd.12913","volume":"25","author":"SM Karppinen","year":"2016","unstructured":"Karppinen SM, Honkanen H-K, Heljasvaara R, Riihil\u00e4 P, Autio-Harmainen H, Sormunen R, Harjunen V, V\u00e4is\u00e4nen MR, V\u00e4is\u00e4nen T, Hurskainen T, Tasanen K, K\u00e4h\u00e4ri VM, Pihlajaniemi T (2016) Collagens XV and XVIII show different expression and localisation in cutaneous squamous cell carcinoma: type XV appears in tumor stroma while XVIII becomes upregulated in tumor cells and lost from microvessels. Exp Dermatol 25:348\u2013354","journal-title":"Exp Dermatol"},{"key":"2457_CR42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1034\/j.1600-0625.2003.120201.x","volume":"12","author":"E Kerkel\u00e4","year":"2003","unstructured":"Kerkel\u00e4 E, Saarialho-Kere U (2003) Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol 12:109\u2013125","journal-title":"Exp Dermatol"},{"key":"2457_CR43","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1046\/j.1523-1747.2000.00993.x","volume":"114","author":"E Kerkel\u00e4","year":"2000","unstructured":"Kerkel\u00e4 E, Ala-Aho R, Jeskanen L, Rechardt O, Grenman R, Shapiro SD, K\u00e4h\u00e4ri VM, Saarialho-Kere U (2000) Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. J Invest Dermatol 114:1113\u20131119","journal-title":"J Invest Dermatol"},{"key":"2457_CR44","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1054\/bjoc.2000.1634","volume":"84","author":"E Kerkel\u00e4","year":"2001","unstructured":"Kerkel\u00e4 E, Ala-aho R, Lohi J, Gr\u00e9nman R, K\u00e4h\u00e4ri VM, Saarialho-Kere U (2001) Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers. Br J Cancer 84:659\u2013669","journal-title":"Br J Cancer"},{"key":"2457_CR45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.matbio.2015.01.022","volume":"44\u201346","author":"K Kessenbrock","year":"2015","unstructured":"Kessenbrock K, Wang CY, Werb Z (2015) Matrix metalloproteinases in stem cell regulation and cancer. Matrix Biol 44\u201346:184\u2013190","journal-title":"Matrix Biol"},{"key":"2457_CR46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5306\/wjco.v4.i4.85","volume":"4","author":"A Kivisaari","year":"2013","unstructured":"Kivisaari A, K\u00e4h\u00e4ri VM (2013) Squamous cell carcinoma of the skin: emerging need for novel biomarkers. World J Clin Oncol 4:85\u201390","journal-title":"World J Clin Oncol"},{"key":"2457_CR47","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1365-2133.2008.08466.x","volume":"158","author":"AK Kivisaari","year":"2008","unstructured":"Kivisaari AK, Kallajoki M, Mirtti T, McGrath JA, Bauer JW, Weber F, Konigova R, Sawamura D, Sato-Matsumura KC, Shimizu H, Csikos M, Sinemus K, Beckert W, K\u00e4h\u00e4ri VM (2008) Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas. Br J Dermatol 158:778\u2013785","journal-title":"Br J Dermatol"},{"key":"2457_CR48","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2133.2010.09924.x","volume":"163","author":"AK Kivisaari","year":"2010","unstructured":"Kivisaari AK, Kallajoki M, Ala-aho R, McGrath JA, Bauer JW, K\u00f6nigov\u00e1 R, Medvecz M, Beckert W, Gr\u00e9nman R, K\u00e4h\u00e4ri VM (2010) Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma. Br J Dermatol 163:726\u2013735","journal-title":"Br J Dermatol"},{"key":"2457_CR49","doi-asserted-by":"crossref","unstructured":"Kloth JN, Gorter A, Fleuren GJ, Oosting J, Uljee S, Haar N ter, Dreef EJ, Kenter GG, Jordanova ES (2008) Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma. J Pathol 215:222\u2013230","DOI":"10.1002\/path.2347"},{"key":"2457_CR50","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/gb-2006-7-5-216","volume":"7","author":"RH Law","year":"2006","unstructured":"Law RH, Zhang Q, McGowan S, Buckle AM, Silverman GA, Wong W, Rosado CJ, Langendorf CG, Pike RN, Bird PI, Whisstock JC (2006) An overview of the serpin superfamily. Genome Biol 7:216","journal-title":"Genome Biol"},{"key":"2457_CR51","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1101\/gad.1484707","volume":"21","author":"K Lefort","year":"2007","unstructured":"Lefort K, Mandinova A, Ostano P, Kolev V, Calpini V, Kolfschoten I, Devgan V, Lieb J, Raffoul W, Hohl D, Neel V, Garlick J, Chiorino G, Dotto GP (2007) Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1\/2 and MRCKalpha kinases. Genes Dev 21:562\u2013577","journal-title":"Genes Dev"},{"key":"2457_CR52","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-14-1773","volume":"21","author":"YY Li","year":"2015","unstructured":"Li YY, Hanna GJ, Laga AC, Haddad RI, Lorch JH, Hammerman PS (2015) Genomic analysis of metastatic cutaneous squamous cell carcinoma. Clin Cancer Res 21:1447\u20131456","journal-title":"Clin Cancer Res"},{"key":"2457_CR53","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.biocel.2014.06.012","volume":"53","author":"YZ Lim","year":"2014","unstructured":"Lim YZ, South AP (2014) Tumour-stroma crosstalk in the development of squamous cell carcinoma. Int J Biochem Cell Biol 53:450\u2013458","journal-title":"Int J Biochem Cell Biol"},{"key":"2457_CR54","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1091\/mbc.E10-03-0242","volume":"21","author":"S Lin","year":"2010","unstructured":"Lin S, Gordon K, Kaplan N, Getsios S (2010) Ligand targeting of EphA2 enhances keratinocyte adhesion and differentiation via desmoglein 1. Mol Biol Cell 21:3902\u20133914","journal-title":"Mol Biol Cell"},{"key":"2457_CR55","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.semcdb.2011.10.017","volume":"23","author":"S Lin","year":"2012","unstructured":"Lin S, Wang B, Getsios S (2012) Eph\/ephrin signaling in epidermal differentiation and disease. Semin Cell Dev Biol 23:92\u2013101","journal-title":"Semin Cell Dev Biol"},{"key":"2457_CR56","first-page":"243","volume":"1835","author":"JE Lisle","year":"2013","unstructured":"Lisle JE, Mertens-Walker I, Rutkowski R, Herington AC, Stephenson SA (2013) Eph receptors and their ligands: promising molecular biomarkers and therapeutic targets in prostate cancer. Biochim Biophys Acta 1835:243\u2013257","journal-title":"Biochim Biophys Acta"},{"key":"2457_CR57","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/hed.20322","volume":"28","author":"M Luukkaa","year":"2006","unstructured":"Luukkaa M, Vihinen P, Kronqvist P, Vahlberg T, Pyrh\u00f6nen S, K\u00e4h\u00e4ri VM, Gr\u00e9nman R (2006) Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer. Head Neck 28:225\u2013234","journal-title":"Head Neck"},{"key":"2457_CR58","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(09)61196-X","volume":"375","author":"V Madan","year":"2010","unstructured":"Madan V, Lear JT, Szeimies RM (2010) Non-melanoma skin cancer. Lancet 375:673\u2013685","journal-title":"Lancet"},{"key":"2457_CR59","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436\u2013444","journal-title":"Nature"},{"key":"2457_CR60","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.aaa6806","volume":"348","author":"I Martincorena","year":"2015","unstructured":"Martincorena I, Roshan A, Gerstung M, Ellis P, Van Loo P, McLaren S, Wedge DC, Fullam A, Alexandrov LB, Tubio JM, Stebbings L, Menzies A, Widaa S, Stratton MR, Jones PH, Campbell PJ (2015) Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348:880\u2013886","journal-title":"Science"},{"key":"2457_CR61","doi-asserted-by":"crossref","first-page":"djv293","DOI":"10.1093\/jnci\/djv293","volume":"108","author":"VL Martins","year":"2016","unstructured":"Martins VL, Caley MP, Moore K, Szentpetery Z, Marsh ST, Murrell DF, Kim MH, Avari M, McGrath JA, Cerio R, Kivisaari A, K\u00e4h\u00e4ri VM, Hodivala-Dilke K, Brennan CH, Chen M, Marshall JF, O\u2019Toole EA (2016) Suppression of TGF\u03b2 and angiogenesis by Type VII Collagen in cutaneous SCC. J Natl Cancer Inst 108:djv293","journal-title":"J Natl Cancer Inst"},{"key":"2457_CR62","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4161\/mabs.29670","volume":"6","author":"S Meyer","year":"2014","unstructured":"Meyer S, Leusen JH, Boross P (2014) Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer. MAbs 6:1133\u20131144","journal-title":"MAbs"},{"key":"2457_CR63","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1158\/0008-5472.CAN-15-1348","volume":"76","author":"VR Mittapalli","year":"2016","unstructured":"Mittapalli VR, Madl J, L\u00f6ffek S, Kiritsi D, Kern JS, R\u00f6mer W, Nystr\u00f6m A, Bruckner-Tuderman L (2016) Injury-driven stiffening of the dermis expedites skin carcinoma progression. Cancer Res 76:940\u2013951","journal-title":"Cancer Res"},{"key":"2457_CR64","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1091\/mbc.E08-06-0549","volume":"20","author":"K Miura","year":"2009","unstructured":"Miura K, Nam JM, Kojima C, Mochizuki N, Sabe H (2009) EphA2 engages Git1 to suppress Arf6 activity modulating epithelial cell-cell contacts. Mol Biol Cell 20:1949\u20131959","journal-title":"Mol Biol Cell"},{"key":"2457_CR65","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.molimm.2011.04.004","volume":"48","author":"SC Nilsson","year":"2011","unstructured":"Nilsson SC, Sim RB, Lea SM, Fremeaux-Bacchi V, Blom AM (2011) Complement factor I in health and disease. Mol Immunol 48:1611\u20131620","journal-title":"Mol Immunol"},{"key":"2457_CR66","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/j.bbagen.2014.03.007","volume":"1840","author":"L Nissinen","year":"2014","unstructured":"Nissinen L, K\u00e4h\u00e4ri VM (2014) Matrix metalloproteinases in inflammation. Biochim Biophys Acta 1840:2571\u20132580","journal-title":"Biochim Biophys Acta"},{"key":"2457_CR67","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00262-015-1658-8","volume":"64","author":"M Okroj","year":"2015","unstructured":"Okroj M, Holmquist E, Nilsson E, Anagnostaki L, Jirstr\u00f6m K, Blom AM (2015) Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence. Cancer Immunol Immunother 64:467\u2013478","journal-title":"Cancer Immunol Immunother"},{"key":"2457_CR68","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cell.2008.03.011","volume":"133","author":"EB Pasquale","year":"2008","unstructured":"Pasquale EB (2008) Eph-ephrin bidirectional signaling in physiology and disease. Cell 133:38\u201352","journal-title":"Cell"},{"key":"2457_CR69","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrc2806","volume":"10","author":"EB Pasquale","year":"2010","unstructured":"Pasquale EB (2010) Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer 10:165\u2013180","journal-title":"Nat Rev Cancer"},{"key":"2457_CR70","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4161\/19336918.2014.970012","volume":"8","author":"BE Perez White","year":"2014","unstructured":"Perez White BE, Getsios S (2014) Eph receptor and ephrin function in breast, gut, and skin epithelia. Cell Adh Migr 8:327\u2013338","journal-title":"Cell Adh Migr"},{"key":"2457_CR71","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2353\/ajpath.2006.060058","volume":"169","author":"I Petrache","year":"2006","unstructured":"Petrache I, Fijalkowska I, Medler TR, Skirball J, Cruz P, Zhen L, Petrache HI, Flotte TR, Tuder RM (2006) Alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol 169:1155\u20131166","journal-title":"Am J Pathol"},{"key":"2457_CR72","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1158\/1078-0432.CCR-14-1768","volume":"20","author":"CR Pickering","year":"2014","unstructured":"Pickering CR, Zhou JH, Lee JJ, Drummond JA, Peng SA, Saade RE, Tsai KY, Curry JL, Tetzlaff MT, Lai SY, Yu J, Muzny DM, Doddapaneni H, Shinbrot E, Covington KR, Zhang J, Seth S, Caulin C, Clayman GL, El-Naggar AK, Gibbs RA, Weber RS, Myers JN, Wheeler DA, Frederick MJ (2014) Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res 20:6582\u20136592","journal-title":"Clin Cancer Res"},{"key":"2457_CR73","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4614-5915-6_11","volume":"772","author":"R Pio","year":"2014","unstructured":"Pio R, Corrales L, Lambris JD (2014) The role of complement in tumor growth. Adv Exp Med Biol 772:229\u2013262","journal-title":"Adv Exp Med Biol"},{"key":"2457_CR74","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1172\/JCI57415","volume":"122","author":"V Ratushny","year":"2012","unstructured":"Ratushny V, Gober MD, Hick R, Ridky TW, Seykora JT (2012) From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest 122:464\u2013472","journal-title":"J Clin Invest"},{"key":"2457_CR75","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11:785\u2013797","journal-title":"Nat Immunol"},{"key":"2457_CR76","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/jid.2013.346","volume":"134","author":"PM Riihil\u00e4","year":"2014","unstructured":"Riihil\u00e4 PM, Nissinen LM, Ala-aho R, Kallajoki M, Gr\u00e9nman R, Meri S, Peltonen S, Peltonen J, K\u00e4h\u00e4ri VM (2014) Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma. J Invest Dermatol 134:498\u2013506","journal-title":"J Invest Dermatol"},{"key":"2457_CR77","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/jid.2014.376","volume":"135","author":"P Riihil\u00e4","year":"2015","unstructured":"Riihil\u00e4 P, Nissinen L, Farshchian M, Kivisaari A, Ala-aho R, Kallajoki M, Gr\u00e9nman R, Meri S, Peltonen S, Peltonen J, K\u00e4h\u00e4ri VM (2015) Complement factor I promotes progression of cutaneous squamous cell carcinoma. J Invest Dermatol 135:579\u2013588","journal-title":"J Invest Dermatol"},{"key":"2457_CR78","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archdermatol.2010.19","volume":"146","author":"HW Rogers","year":"2010","unstructured":"Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, Coldiron BM (2010) Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 146:283\u2013287","journal-title":"Arch Dermatol"},{"key":"2457_CR79","doi-asserted-by":"crossref","first-page":"6258","DOI":"10.1158\/0008-5472.CAN-06-0539","volume":"66","author":"DV Rozanov","year":"2006","unstructured":"Rozanov DV, Savinov AY, Golubkov VS, Tomlinson S, Strongin AY (2006) Interference with the complement system by tumor cell membrane type-1 matrix metalloproteinase plays a significant role in promoting metastasis in mice. Cancer Res 66:6258\u20136263","journal-title":"Cancer Res"},{"key":"2457_CR80","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00011-010-0220-6","volume":"59","author":"MJ Rutkowski","year":"2010","unstructured":"Rutkowski MJ, Sughrue ME, Kane AJ, Ahn BJ, Fang S, Parsa AT (2010a) The complement cascade as a mediator of tissue growth and regeneration. Inflamm Res 59:897\u2013905","journal-title":"Inflamm Res"},{"key":"2457_CR81","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1158\/1541-7786.MCR-10-0225","volume":"8","author":"MJ Rutkowski","year":"2010","unstructured":"Rutkowski MJ, Sughrue ME, Kane AJ, Mills SA, Parsa AT (2010b) Cancer and the complement cascade. Mol Cancer Res 8:1453\u20131465","journal-title":"Mol Cancer Res"},{"key":"2457_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.57","author":"Y Shaked","year":"2016","unstructured":"Shaked Y (2016) Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects. Nat Rev Clin Oncol. doi: 10.1038\/nrclinonc.2016.57","journal-title":"Nat Rev Clin Oncol"},{"key":"2457_CR83","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0901-5027(87)80096-6","volume":"16","author":"K Shirasuna","year":"1987","unstructured":"Shirasuna K, Sugiyama M, Watatani K, Morioka S, Hayashido Y (1987) Serum alpha-1-antitrypsin in patients with malignant tumors occurring in the oral region. Int J Oral Maxillofac Surg 16:516\u2013520","journal-title":"Int J Oral Maxillofac Surg"},{"key":"2457_CR84","doi-asserted-by":"crossref","first-page":"33293","DOI":"10.1074\/jbc.R100016200","volume":"276","author":"GA Silverman","year":"2001","unstructured":"Silverman GA, Bird PI, Carrell RW, Church FC, Coughlin PB, Gettins PG, Irving JA, Lomas DA, Luke CJ, Moyer RW, Pemberton PA, Remold-O\u2019Donnell E, Salvesen GS, Travis J, Whisstock JC (2001) The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem 276:33293\u201333296","journal-title":"J Biol Chem"},{"key":"2457_CR85","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00018-003-3240-3","volume":"61","author":"GA Silverman","year":"2004","unstructured":"Silverman GA, Whisstock JC, Askew DJ, Pak SC, Luke CJ, Cataltepe S, Irving JA, Bird PI (2004) Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis. Cell Mol Life Sci 61:301\u2013325","journal-title":"Cell Mol Life Sci"},{"key":"2457_CR86","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/bst0320021","volume":"32","author":"RB Sim","year":"2004","unstructured":"Sim RB, Tsiftsoglou SA (2004) Proteases of the complement system.Biochem Soc Trans 32:21\u201327","journal-title":"Biochem Soc Trans"},{"key":"2457_CR87","doi-asserted-by":"crossref","unstructured":"South AP, Purdie KJ, Watt SA, Haldenby S, Breems NY den, Dimon M, Arron ST, Kluk MJ, Aster JC, McHugh A, Xue DJ, Dayal JH, Robinson KS, Rizvi SM, Proby CM, Harwood CA, Leigh IM (2014) NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis. J Invest Dermatol 134:2630\u20132638","DOI":"10.1038\/jid.2014.154"},{"key":"2457_CR88","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1517\/13543784.9.12.2913","volume":"9","author":"WP Steward","year":"2000","unstructured":"Steward WP, Thomas AL (2000) Marimastat: the clinical development of a matrix metalloproteinase inhibitor. Expert Opin Investig Drugs 9:2913\u20132922","journal-title":"Expert Opin Investig Drugs"},{"key":"2457_CR89","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1158\/1078-0432.CCR-09-2525","volume":"16","author":"A Stokes","year":"2010","unstructured":"Stokes A, Joutsa J, Ala-Aho R, Pitchers M, Pennington CJ, Martin C, Premachandra DJ, Okada Y, Peltonen J, Grenman R, James HA, Edwards DR, K\u00e4h\u00e4ri VM (2010) Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma. Clin Cancer Res 16:2022\u20132035","journal-title":"Clin Cancer Res"},{"key":"2457_CR90","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archdermatol.2009.377","volume":"146","author":"G Tessari","year":"2010","unstructured":"Tessari G, Naldi L, Boschiero L, Nacchia F, Fior F, Forni A, Rugiu C, Faggian G, Sassi F, Gotti E, Fiocchi R, Talamini G, Girolomoni G (2010) Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study. Arch Dermatol 146:294\u2013299","journal-title":"Arch Dermatol"},{"key":"2457_CR91","first-page":"231475","volume":"2011","author":"AP Tufaro","year":"2011","unstructured":"Tufaro AP, Chuang JC, Prasad N, Chuang A, Chuang TC, Fischer AC (2011) Molecular markers in cutaneous squamous cell carcinoma. Int J Surg Oncol 2011:231475","journal-title":"Int J Surg Oncol"},{"key":"2457_CR92","first-page":"1005","volume":"152","author":"M Vaalamo","year":"1998","unstructured":"Vaalamo M, Karjalainen-Lindsberg ML, Puolakkainen P, Kere J, Saarialho-Kere U (1998) Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol 152:1005\u20131014","journal-title":"Am J Pathol"},{"key":"2457_CR93","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.4049\/jimmunol.150.9.4052","volume":"150","author":"V V\u0115tvicka","year":"1993","unstructured":"V\u0115tvicka V, Reed W, Hoover ML, Ross GD (1993) Complement factors H and I synthesized by B cell lines function to generate a growth factor activity from C3. J Immunol 150:4052\u20134060","journal-title":"J Immunol"},{"key":"2457_CR94","doi-asserted-by":"crossref","first-page":"920595","DOI":"10.1155\/2013\/920595","volume":"2013","author":"ST Vilen","year":"2013","unstructured":"Vilen ST, Salo T, Sorsa T, Nyberg P (2013) Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma. ScientificWorldJournal 2013:920595","journal-title":"ScientificWorldJournal"},{"key":"2457_CR95","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1002\/jcp.22968","volume":"227","author":"R Walsh","year":"2012","unstructured":"Walsh R, Blumenberg M (2012) Eph-2B, acting as an extracellular ligand, induces differentiation markers in epidermal keratinocytes. J Cell Physiol 227:2330\u20132340","journal-title":"J Cell Physiol"},{"key":"2457_CR96","doi-asserted-by":"crossref","unstructured":"Wisgerhof HC, Boog PJ van der, Fijter JW de, Wolterbeek R, Haasnoot GW, Claas FH, Willemze R, Bouwes Bavinck JN (2009) Increased risk of squamous-cell carcinoma in simultaneous pancreas kidney transplant recipients compared with kidney transplant recipients. J Invest Dermatol 129:2886\u20132894","DOI":"10.1038\/jid.2009.181"},{"key":"2457_CR97","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2867-4-7","volume":"4","author":"I Zelvyte","year":"2004","unstructured":"Zelvyte I, Stevens T, Westin U, Janciauskiene S (2004) Alpha1-antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil-conditioned medium on lung cancer HCC cells, in vitro. Cancer Cell Int 4:7","journal-title":"Cancer Cell Int"},{"key":"2457_CR98","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-5699(98)01432-7","volume":"20","author":"PF Zipfel","year":"1999","unstructured":"Zipfel PF, Skerka C (1999) FHL-1\/reconectin: a human complement and immune regulator with cell-adhesive function. Immunol Today 20:135\u2013140","journal-title":"Immunol Today"},{"key":"2457_CR99","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","volume":"9","author":"PF Zipfel","year":"2009","unstructured":"Zipfel PF, Skerka C (2009) Complement regulators and inhibitory proteins. Nat Rev Immunol 9:729\u2013740","journal-title":"Nat Rev Immunol"}],"container-title":["Cell and Tissue Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-016-2457-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00441-016-2457-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-016-2457-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T06:36:11Z","timestamp":1718692571000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00441-016-2457-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,14]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["2457"],"URL":"https:\/\/doi.org\/10.1007\/s00441-016-2457-z","relation":{},"ISSN":["0302-766X","1432-0878"],"issn-type":[{"value":"0302-766X","type":"print"},{"value":"1432-0878","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,14]]}}}